Comprehensive Consult Note for Recurrent UTI Patient
A comprehensive consult note for a patient with recurrent UTIs should include detailed assessment of risk factors, diagnostic evaluation, and a clear treatment and prevention plan to reduce morbidity and mortality associated with recurrent infections. 1, 2
Patient Assessment Components
History
- Definition of recurrence: Document if patient meets criteria for recurrent UTI (≥3 episodes in 12 months or ≥2 episodes in 6 months) 1, 3
- Infection pattern:
- Timing of previous infections
- Relationship to sexual activity
- Previous culture results and antibiotic responses
- Differentiation between reinfection vs. relapse 1
Risk Factor Assessment
- Sexual habits: Frequency, new partners, use of spermicides 1, 4
- Hygiene practices: Wiping technique, douching 4
- Voiding habits: Post-coital voiding, delayed urination, fluid intake 2, 4
- Medical conditions: Diabetes, immunosuppression 1, 5
- Anatomical factors: History of urinary tract surgery/trauma, prior calculi 1
- Menopausal status: Presence of atrophic vaginitis 1, 2
- Functional issues: Urinary incontinence, cystocele, high post-void residuals 1
Physical Examination
- Focused pelvic exam to assess for:
- Atrophic vaginitis in postmenopausal women
- Cystocele or other pelvic organ prolapse
- Signs of fistula formation
Diagnostic Evaluation
Urine studies:
Imaging considerations:
Post-void residual measurement: Especially important in older women 1
Treatment and Management Plan
Acute Episode Management
- Antibiotic selection:
- Document selected antibiotic based on culture results and local resistance patterns
- First-line options: Nitrofurantoin, TMP-SMX (if local resistance <20%) 2
- Alternative: Fosfomycin (note: lower clinical and microbiologic resolution compared to nitrofurantoin) 2, 6
- Reserve fluoroquinolones for complicated cases due to side effects 2
- Treatment duration: 5-7 days for uncomplicated cystitis 2
Prevention Strategy
Non-antimicrobial measures:
Antimicrobial prophylaxis options (if ≥3 UTIs in 12 months):
- Post-coital prophylaxis: Single dose within 2 hours of intercourse (if UTIs related to sexual activity) 2, 8
- Continuous low-dose prophylaxis: 6-12 months duration (for UTIs unrelated to sexual activity) 2
- Self-start therapy: For reliable patients who can obtain urine specimens before starting antibiotics 2
- Non-antibiotic option: Methenamine hippurate 1g twice daily 2
Follow-up Plan
- Timing of follow-up appointment
- Indications for repeat urine culture (not necessary if asymptomatic) 2
- Criteria for specialist referral if no improvement
- Duration of prophylaxis (typically 6 months minimum) 8
Patient Education
- Explanation of UTI pathophysiology and recurrence risk
- Self-care measures and lifestyle modifications
- Warning signs requiring immediate medical attention
- Instructions for self-start therapy if prescribed
Pitfalls to Avoid
- Overuse of imaging: Not routinely indicated for uncomplicated recurrent UTIs 1
- Inadequate treatment duration: Too short courses may lead to relapse 2
- Fluoroquinolone overuse: Reserve for complicated cases due to side effect risks 2
- Treating asymptomatic bacteriuria: May increase risk of antibiotic resistance 1, 2
- Failure to address modifiable risk factors: Such as spermicide use, inadequate hydration 1, 4
- Missing complicated UTI: Watch for signs of pyelonephritis, structural abnormalities 1
By including these comprehensive elements in your consult note, you will provide a thorough assessment and management plan that addresses both the immediate infection and long-term prevention strategies to reduce morbidity and improve quality of life for patients with recurrent UTIs.